IceCure Medical Ltd.

The momentum for this stock is not very good. IceCure Medical Ltd. is not a good value stock. IceCure Medical Ltd. is not very popular among insiders. Tradey thinks it is not wise to invest in IceCure Medical Ltd..
Log in to see more information.

News

IceCure to Meet Institutional Investors at the H.C. Wainwright and Lake Street Capital Markets Conferences
IceCure to Meet Institutional Investors at the H.C. Wainwright and Lake Street Capital Markets Conferences

PR Newswire IceCure to Meet Institutional Investors at the H.C. Wainwright and Lake Street Capital Markets Conferences IceCure to Meet Institutional Investors at the H.C. Wainwright and Lake Street Capital...\n more…

USPTO Grants Notice of Allowance for Additional Patent on IceCure's Novel Cryogenic Pump Technology: Reinforces IceCure's Global IP Leadership in Cryoablation Technologies
USPTO Grants Notice of Allowance for Additional Patent on IceCure's Novel Cryogenic Pump Technology: Reinforces IceCure's Global IP Leadership in Cryoablation Technologies

PR Newswire USPTO Grants Notice of Allowance for Additional Patent on IceCure's Novel Cryogenic Pump Technology: Reinforces IceCure's Global IP Leadership in Cryoablation Technologies USPTO Grants Notice of...\n more…

Icecure Medical Poised for Growth: A Comprehensive Buy Recommendation
Icecure Medical Poised for Growth: A Comprehensive Buy Recommendation

TipRanks Financial Blog Maxim Group analyst Anthony Vendetti has reiterated their bullish stance on ICCM stock, giving a Buy rating today. Anthony Vendetti has given his B...\n more…

ICCM Stock Earnings: Icecure Medical Beats EPS, Beats Revenue for Q2 2024
ICCM Stock Earnings: Icecure Medical Beats EPS, Beats Revenue for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nICCM stock results show that Icecure Medical beat analyst estimates for earnings per share and beat on revenue for the second quarter of...\n more…

IceCure Medical Ltd. (ICCM) Reports Q2 Loss, Tops Revenue Estimates
IceCure Medical Ltd. (ICCM) Reports Q2 Loss, Tops Revenue Estimates

Zacks Investment Research IceCure Medical Ltd. (ICCM) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.09 per share a year ago. These...\n more…

60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q2 Loss, Tops Revenue Estimates
60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q2 Loss, Tops Revenue Estimates

Zacks Investment Research 60 Degrees Pharmaceuticals Inc. (SXTP) came out with a quarterly loss of $4.23 per share versus the Zacks Consensus Estimate of a loss of $3.96. This compares to loss of $16.81 per share a year ago...\n more…